• Learning Objective 1:   Describe the current evidence for and against general population screening for celiac disease.
  • Learning Objective 2:   Delineate the current recommendations for celiac disease screening in at-risk populations.
  • Learning Objective 3:   Detail differences in celiac disease screening and diagnosis in individuals with Down syndrome.
Session date: 
12/15/2022 - 12:00pm to 1:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Marisa Stahl, MD, MSCS